Oncology Research International Ltd
Investigate, develop new, effective & low cost plant-derived immune-oncology therapies for treatment of cancer
Location
Year Founded
Not Specified
Company Size
Not Specified
Hiring
No Job Openings
Funding Raised
Not Specified
Website
Log In to Access
Not Specified
Not Specified
Not Specified
About Oncology Research International Ltd
Founded by a cancer survivor, it has been carrying on the research work in low-cost & effective treatment of cancer based on chemical compounds found in natural recurring substance, using traditional Chinese medicine (TCM) approach;
Currently the Company’s new chemical entity ORIL19 has been approved strong efficacy in curing liver & breasts cancer during pre-clinical research; the Company has been strongly encouraged & approved by US FDA to conduct clinical phase 1 research, but is in need of approx. AU$2-5m (US$1.5m) for funding the regulatory filing costs & ongoing research expenses
Founders & Leadership
Financials Beta
Business Model: Not Specified
Revenues: Not Specified
Expenses: Not Specified
Debt: Request
Operating Status: Active
Funding Raised: $0
Investment Rounds: 0 Rounds
Funding Stage: Not Specified
Last Funding Date: Not Specified